Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
54
Recruiting, any sponsor type, condition "cystic fibrosis"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed559
54 trials
Showing 1 to 25, recently updated first.
Johns Hopkins UniversityAcademic, hospital or other
NCT05704036 · 75 participants (planned) · Start May 2, 2023 · Primary completion Jan 2028
Drug: Transdermal estrogen; Progesterone · For: Cystic Fibrosis; Hypoestrogenism
Sites: Baltimore, Maryland
- Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator TherapyPivotal-lookingRecruiting
Indiana UniversityAcademic, hospital or other
NCT06996951 · 64 participants (planned) · Start Jul 2, 2025 · Primary completion Jul 2027
Drug: CONTINUE NASAL SALINE IRRIGATION WITH OR WITHOUT STEROID · For: Cystic Fibrosis (CF); Chronic Rhinosinusitis (CRS)
Sites: Indianapolis, Indiana
SpliSense Ltd.Industry
NCT06429176 · 64 participants (planned) · Start Jun 24, 2024 · Primary completion Oct 1, 2027
Drug: SPL84 · For: Cystic Fibrosis
Sites: Long Beach, California; Los Angeles, California; San Francisco, California · 27 sites in all
- A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis BronchiectasisPivotal-lookingRecruiting
NCT07720375 · 300 participants (planned) · Start Aug 5, 2026 · Primary completion Feb 28, 2029
Drug: Galvokimig; Placebo · For: Non-cystic Fibrosis Bronchiectasis
Sites: Newport Beach, California; Brandon, Florida; Plantation, Florida · 7 sites in all
Azienda Ospedaliera Universitaria Integrata VeronaAcademic, hospital or other
NCT07289035 · 35 participants (planned) · Start Jan 22, 2026 · Primary completion Jun 30, 2027
Drug: Tamoxifen Citrate 20Mg Tab · For: Cystic Fibrosis - Complete
Sites: Verona, Italy
Haisco Pharmaceutical Group Co., Ltd.Industry
NCT07915024 · 47 participants (planned) · Start Aug 6, 2026 · Primary completion Nov 2026
Drug: HSK31858 tablet; Placebo and 1 more · For: Non-cystic Fibrosis Bronchiectasis (NCFBE)
Sites: Jinan, China
Haisco Pharmaceutical Group Co., Ltd.Industry
NCT07915011 · 24 participants (planned) · Start May 26, 2026 · Primary completion Nov 2026
Drug: HSK31858 tablets · For: Non-cystic Fibrosis Bronchiectasis (NCFBE)
Sites: Zhenzhou, China
Haisco Pharmaceutical Group Co., Ltd.Industry
NCT07913009 · 30 participants (planned) · Start Mar 16, 2026 · Primary completion Dec 2026
Drug: HSK31858 tablets · For: Non-cystic Fibrosis Bronchiectasis (NCFBE)
Sites: Zhenzhou, China
- Phase 2 Study to Assess the Safety and Efficacy of ANG003Pivotal-lookingRecruiting
Anagram Therapeutics, Inc.Industry
NCT07450547 · 113 participants (planned) · Start Apr 24, 2026 · Primary completion Jul 2027
Drug: ANG003 Dose A; ANG003 Dose B and 1 more · For: Exocrine Pancreatic Insufficiency (EPI); Cystic Fibrosis (CF)
Sites: Long Beach, California; Los Angeles, California; Denver, Colorado · 28 sites in all
- A Phase II Study of Ensifentrine in Non-Cystic Fibrosis BronchiectasisPivotal-lookingRecruiting
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USAIndustry
NCT06559150 · 284 participants (planned) · Start Sep 11, 2024 · Primary completion Sep 24, 2027
Drug: Nebulized Ensifentrine Suspension; 3 mg; Nebulized Placebo Solution · For: Non-cystic Fibrosis Bronchiectasis
Sites: Birmingham, Alabama; Los Angeles, California; Sacramento, California · 51 sites in all
- Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis ExacerbationsPivotal-lookingRecruiting
Post Graduate Institute of Medical Education and Research, ChandigarhAcademic, hospital or other
NCT06160713 · 80 participants (planned) · Start Dec 1, 2023 · Primary completion Dec 31, 2027
Drug: Itraconazole 65 MG · For: Bronchiectasis; Bronchiectasis Adult
Sites: Chandigarh, India
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT06147414 · 550 participants (planned) · Start Oct 23, 2024 · Primary completion May 2027
Drug: Blood sample · For: Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including; Sickle Cell Disease; Cystic Fibrosis and 12 more
Sites: Paris, France
- Evaluation of VX-581 in Healthy Participants and in Participants With Cystic FibrosisPivotal-lookingRecruiting
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT07283770 · 152 participants (planned) · Start Dec 9, 2025 · Primary completion Jul 12, 2027
Drug: VX-581; Placebo and 5 more · For: Cystic Fibrosis
Sites: Overland Park, Kansas
- Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)Pivotal-lookingRecruiting
CSL BehringIndustry
NCT07048262 · 180 participants (planned) · Start Sep 3, 2025 · Primary completion May 6, 2029
Drug: CSL787; Placebo · For: Non-cystic Fibrosis Bronchiectasis
Sites: Queensland, Australia; Westmead, Australia; Chikushino-shi, Japan · 13 sites in all
Istituto Giannina GasliniAcademic, hospital or other
NCT07809867 · 50 participants (planned) · Start Sep 18, 2026 · Primary completion Apr 2028
Drug: Elexacaftor, Tezacaftor, Ivacaftor; Ivacaftor (VX-770) · For: Cystic Fibrosis (CF)
Sites: Genova, Italy
Ghady HaidarAcademic, hospital or other
NCT07275905 · 12 participants (planned) · Start Aug 20, 2026 · Primary completion Jan 2028
Drug: AchromoPhage · For: Cystic Fibrosis (CF); Achromobacter Infection
Sites: Pittsburgh, Pennsylvania
Children's Hospital Medical Center, CincinnatiAcademic, hospital or other
NCT04793867 · 100 participants (planned) · Start Feb 8, 2021 · Primary completion Dec 31, 2027
Drug: Xenon · For: Cystic Fibrosis; Non-CF Bronchiectasis
Sites: Cincinnati, Ohio
Aimmune Nestlé Health Science US R&D, LLCIndustry
NCT07559175 · 66 participants (planned) · Start Oct 2026 · Primary completion Jun 2027
Drug: NHS7108; Zenpep® · For: Exocrine Pancreatic Insufficiency (EPI); Cystic Fibrosis (CF); Pancreatic Enzyme Abnormality and 1 more
Sites: Scottsdale, Arizona; Little Rock, Arkansas; Los Angeles, California · 39 sites in all
- Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 YearsRecruiting
Peking Union Medical College HospitalAcademic, hospital or other
NCT07485543 · 24 participants (planned) · Start Apr 3, 2026 · Primary completion Dec 2026
Drug: BMD003 (CFTR mRNA) · For: Cystic Fibrosis
Sites: Beijing, China
- Azithromycin to Modify Bronchiectasis Exacerbation RiskPivotal-lookingRecruiting
Assiut UniversityAcademic, hospital or other
NCT07608328 · 500 participants (planned) · Start Jun 29, 2026 · Primary completion Jun 21, 2027
Drug: Azithromycin; Matching Placebo · For: Non-cystic Fibrosis Bronchiectasis; Bronchiectasis Adult; Bronchiectasis and 1 more
Sites: Asyut, Egypt
- Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsPivotal-lookingRecruiting
Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
NCT07437105 · 160 participants (planned) · Start Feb 25, 2026 · Primary completion Jun 26, 2027
Drug: VX-272; Placebo and 2 more · For: Cystic Fibrosis
Sites: Tempe, Arizona
University of California, Los AngelesAcademic, hospital or other
NCT06191640 · 80 participants (planned) · Start Apr 12, 2023 · Primary completion Jun 30, 2029
Drug: Ivacaftor or elexacaftor/tezacaftor/ivacaftor · For: Cystic Fibrosis in Children; Cystic Fibrosis; Chronic Rhinosinusitis (Diagnosis) and 2 more
Sites: Aurora, Colorado; Iowa City, Iowa; Kansas City, Kansas · 6 sites in all
Michael R. Rickels, MD, MSAcademic, hospital or other
NCT06995651 · 15 participants (planned) · Start Oct 21, 2025 · Primary completion Jul 2027
Drug: Dorzagliatin; Placebo · For: Pancreatic Insufficiency; Cystic Fibrosis-related Diabetes
Sites: Philadelphia, Pennsylvania · 2 sites in all
- Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With BronchiectasisPivotal-lookingRecruiting
Centre Hospitalier Intercommunal CreteilAcademic, hospital or other
NCT06368804 · 196 participants (planned) · Start Sep 15, 2024 · Primary completion Mar 15, 2025
Drug: Antibiotic monotherapy treatment and follow-up; Antibiotic bitherapy treatment and follow-up · For: Bronchiectasis
Sites: Amiens, France; Bordeaux, France; Brest, France · 18 sites in all
Sonya HeltsheAcademic, hospital or other
NCT04509050 · 210 participants (planned) · Start Nov 18, 2020 · Primary completion Dec 31, 2027
Drug: Ivacaftor or elexacaftor/tezacaftor/ivacaftor · For: Cystic Fibrosis
Sites: Birmingham, Alabama; Palo Alto, California; Aurora, Colorado · 35 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.